![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pluristem Scoops Up Orphan Drug Designation for PLX-PAD Cells
Pluristem Scoops Up Orphan Drug Designation for PLX-PAD Cells
Pluristem Therapeutics has scooped up FDA orphan drug designation for its PLX-PAD cells for the treatment of severe preeclampsia.
Preeclampsia — which has no cure except delivery — is one of the most common medical complications of pregnancy.
Upcoming Events
-
21Oct